TY - JOUR
T1 - Prevention of Surgical Site Infections in Neonates and Children
T2 - Non-Pharmacological Measures of Prevention
AU - on behalf of the Peri-Operative Prophylaxis in Neonatal Paediatric Age (POP-NeoPed) Study Group
AU - Meoli, Aniello
AU - Ciavola, Lorenzo
AU - Rahman, Sofia
AU - Masetti, Marco
AU - Toschetti, Tommaso
AU - Morini, Riccardo
AU - Dal Canto, Giulia
AU - Auriti, Cinzia
AU - Caminiti, Caterina
AU - Castagnola, Elio
AU - Conti, Giorgio
AU - Donà, Daniele
AU - Galli, Luisa
AU - La Grutta, Stefania
AU - Lancella, Laura
AU - Lima, Mario
AU - Lo Vecchio, Andrea
AU - Pelizzo, Gloria
AU - Petrosillo, Nicola
AU - Simonini, Alessandro
AU - Venturini, Elisabetta
AU - Caramelli, Fabio
AU - Gargiulo, Gaetano Domenico
AU - Sesenna, Enrico
AU - Sgarzani, Rossella
AU - Vicini, Claudio
AU - Zucchelli, Mino
AU - Mosca, Fabio
AU - Staiano, Annamaria
AU - Principi, Nicola
AU - Esposito, Susanna
N1 - Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2022/7
Y1 - 2022/7
N2 - A surgical site infection (SSI) is an infection that occurs in the incision created by an invasive surgical procedure. Although most infections are treatable with antibiotics, SSIs remain a significant cause of morbidity and mortality after surgery and have a significant economic impact on health systems. Preventive measures are essential to decrease the incidence of SSIs and antibiotic abuse, but data in the literature regarding risk factors for SSIs in the pediatric age group are scarce, and current guidelines for the prevention of the risk of developing SSIs are mainly focused on the adult population. This document describes the current knowledge on risk factors for SSIs in neonates and children undergoing surgery and has the purpose of providing guidance to health care professionals for the prevention of SSIs in this population. Our aim is to consider the possible non-pharmacological measures that can be adopted to prevent SSIs. To our knowledge, this is the first study to provide recommendations based on a careful review of the available scientific evidence for the non-pharmacological prevention of SSIs in neonates and children. The specific scenarios developed are intended to guide the healthcare professional in practice to ensure standardized management of the neonatal and pediatric patients, decrease the incidence of SSIs and reduce antibiotic abuse.
AB - A surgical site infection (SSI) is an infection that occurs in the incision created by an invasive surgical procedure. Although most infections are treatable with antibiotics, SSIs remain a significant cause of morbidity and mortality after surgery and have a significant economic impact on health systems. Preventive measures are essential to decrease the incidence of SSIs and antibiotic abuse, but data in the literature regarding risk factors for SSIs in the pediatric age group are scarce, and current guidelines for the prevention of the risk of developing SSIs are mainly focused on the adult population. This document describes the current knowledge on risk factors for SSIs in neonates and children undergoing surgery and has the purpose of providing guidance to health care professionals for the prevention of SSIs in this population. Our aim is to consider the possible non-pharmacological measures that can be adopted to prevent SSIs. To our knowledge, this is the first study to provide recommendations based on a careful review of the available scientific evidence for the non-pharmacological prevention of SSIs in neonates and children. The specific scenarios developed are intended to guide the healthcare professional in practice to ensure standardized management of the neonatal and pediatric patients, decrease the incidence of SSIs and reduce antibiotic abuse.
KW - neonatal infection
KW - pediatric infectious diseases
KW - pediatric surgery
KW - prevention
KW - surgical site infection
UR - http://www.scopus.com/inward/record.url?scp=85133416479&partnerID=8YFLogxK
U2 - 10.3390/antibiotics11070863
DO - 10.3390/antibiotics11070863
M3 - Article
AN - SCOPUS:85133416479
SN - 2079-6382
VL - 11
JO - Antibiotics
JF - Antibiotics
IS - 7
M1 - 863
ER -